Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-13-006896
Filing Date
2013-06-12
Accepted
2013-06-12 06:05:35
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1/A a2215641zs-1a.htm S-1/A 1991520
2 EX-1.1 a2215641zex-1_1.htm EX-1.1 218273
3 EX-3.1 a2215641zex-3_1.htm EX-3.1 388453
4 EX-3.2 a2215641zex-3_2.htm EX-3.2 45859
5 EX-4.1 a2215641zex-4_1.htm EX-4.1 12884
6 EX-5.1 a2215641zex-5_1.htm EX-5.1 8393
7 EX-10.2 a2215641zex-10_2.htm EX-10.2 359781
8 EX-23.1 a2215641zex-23_1.htm EX-23.1 2675
9 G91842KI01I001.GIF g91842ki01i001.gif GRAPHIC 157221
10 G91842KI03I001.GIF g91842ki03i001.gif GRAPHIC 108207
11 G1041595.JPG g1041595.jpg GRAPHIC 26746
12 G679275.JPG g679275.jpg GRAPHIC 20480
13 G490766.JPG g490766.jpg GRAPHIC 54950
  Complete submission text file 0001047469-13-006896.txt   3536126
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-188595 | Film No.: 13907861
SIC: 2834 Pharmaceutical Preparations